UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

European urology, 2014-07, Vol.66 (1), p.22-29

2014

Volltextzugriff (PDF)

Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer

European urology, 2010-05, Vol.57 (5), p.830-835

2010

Volltextzugriff (PDF)

The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation

European urology, 2011-07, Vol.60 (1), p.106-117

2011

Volltextzugriff (PDF)

Stratifying Risk — The U.S. Preventive Services Task Force and Prostate-Cancer Screening

The New England journal of medicine, 2011-11, Vol.365 (21), p.1953-1955

Schröder, Fritz H

2011

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer

European urology, 2012-01, Vol.61 (1), p.11-25

2012

Volltextzugriff (PDF)

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

BJU international, 2008-12, Vol.102 (11), p.1531-1538

2008

Volltextzugriff (PDF)

Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

Journal of clinical oncology, 2010-05, Vol.28 (15), p.2493-2498

2010

Volltextzugriff (PDF)

A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

European urology, 2010-01, Vol.57 (1), p.79-85

2010

Volltextzugriff (PDF)

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer

Modern pathology, 2012-03, Vol.25 (3), p.471-479

2012

Volltextzugriff (PDF)

Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4178-4186

2007

Volltextzugriff (PDF)

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

European urology, 2010-05, Vol.57 (5), p.836-842

2010

Volltextzugriff (PDF)

Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications

European urology, 2009-06, Vol.55 (6), p.1321-1332

2009

Volltextzugriff (PDF)

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer

The Journal of urology, 2011-09, Vol.186 (3), p.889-897

2011

Volltextzugriff (PDF)

Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets

European urology, 2009-10, Vol.56 (4), p.594-605

2009

Volltextzugriff (PDF)

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

Clinical cancer research, 2010-06, Vol.16 (12), p.3232-3239

2010

Volltextzugriff (PDF)

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

Annals of internal medicine, 2008-10, Vol.149 (7), p.461

2008

Volltextzugriff (PDF)

Leaf thickness and turgor pressure in bean during plant desiccation

Scientia horticulturae, 2015-03, Vol.184, p.55-62

2015

Volltextzugriff (PDF)

Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial

European urology, 2013-12, Vol.64 (6), p.873-875

2013

Volltextzugriff (PDF)

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice

The Journal of urology, 2008-07, Vol.180 (1), p.150-154

2008

Volltextzugriff (PDF)

The influence of family history on prostate cancer risk: implications for clinical management

BJU international, 2011-03, Vol.107 (5), p.716-721

2011

Volltextzugriff (PDF)

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

Current opinion in urology, 2009-05, Vol.19 (3), p.227-231

2009

Volltextzugriff (PDF)

RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection

JNCI : Journal of the National Cancer Institute, 2014-05, Vol.106 (5)

2014

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(220)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(206)
Deutsch
(76)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(26)
European Urology
(18)
European Policy Analysis
(9)
The Prostate
(9)
Bju International
(6)
Cheminform
(4)
Plos One
(4)
Zeitschrift Für Deutsches Altertum Und Deutsche Literatur
(4)
Angewandte Chemie
(3)
Chemische Berichte
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies

Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer

The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation

Stratifying Risk — The U.S. Preventive Services Task Force and Prostate-Cancer Screening

Screening and Prostate-Cancer Mortality in a Randomized European Study

Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications

A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer

Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

Leaf thickness and turgor pressure in bean during plant desiccation

Prospective Randomized Evaluation of Risk-adapted Prostate-specific Antigen Screening in Young Men: The PROBASE Trial

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice

The influence of family history on prostate cancer risk: implications for clinical management

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection

Suchergebnisse filtern